Swietenia macrophyllaExtract-Coated Selenium Nanoparticles Protect Against Diabetes-Induced Testicular Damage Via Antioxidative and Anti-Inflammatory Mechanisms

نویسندگان
doi
10.48309/jaoc.2026.566308.1375
چکیده

Diabetes mellitus induces oxidative stress and inflammation that contribute to testicular dysfunction and impaired spermatogenesis. This study evaluated the protective potential of Swietenia macrophylla extract-coated selenium nanoparticles (SM-SeNPs) against streptozotocin (STZ)–induced testicular injury in rats. Adult male rats were divided into a control group (normal rats); diabetic groups (rats injected with a single intraperitoneal of STZ), and SM-SeNP group (rats injected with a single intraperitoneal of STZ and received SM-NP treatment at different doses, including 75, 150, and 300 mg/kg body weight). Testicular malondialdehyde (MDA), antioxidants (SOD and GPx), and inflammatory mediators (IL-6 and TNF-α) were quantified using ELISA, while NRF2 and NF-κB expression were investigated by immunohistochemistry. Histopathological analyses were conducted to assess seminiferous tubule morphology, germ cell organization, Sertoli and Leydig cell integrity, and overall testicular architecture. STZ administration markedly (p < 0.05) increased MDA levels, NF-κB expression, and the pro-inflammatory cytokines IL-6 and TNF-α levels, while significantly decreasing NRF2 expression and the antioxidant enzymes SOD and GPx. Treatment with SM-SeNPs, particularly at 300 mg/kg, significantly (p < 0.05) reduced MDA levels, NF-κB expression, IL-6, and TNF-α levels and restored NRF2 levels, SOD, and GPx levels to near-normal levels. Histologically, STZ caused pronounced degenerative changes in the seminiferous tubules, including reduced tubular diameter, germ cell depletion, apoptotic alterations, Sertoli cell vacuolization, and Leydig cell loss. SM-SeNPs at 300 mg/kg substantially ameliorated these abnormalities, preserving tubular structure, improving spermatogenic layers, and maintaining Sertoli and Leydig cell morphology similar to the normal control group. SM-SeNPs provide robust protection against diabetes-induced testicular damage by enhancing antioxidant defenses, suppressing inflammatory pathways, and restoring normal testicular histoarchitecture. These findings highlight SM-SeNPs as a promising therapeutic candidate for mitigating male reproductive dysfunction associated with diabetes .